Inhibikase Therapeutics Inc banner

Inhibikase Therapeutics Inc
NASDAQ:IKT

Watchlist Manager
Inhibikase Therapeutics Inc Logo
Inhibikase Therapeutics Inc
NASDAQ:IKT
Watchlist
Price: 2.33 USD -3.32% Market Closed
Market Cap: $307.6m

DCF Value

The DCF Value for Inhibikase Therapeutics Inc (IKT) under the Base Case is -0.97 USD. Compared with the current market price of 2.33 USD, the stock appears Overvalued by 100% .

Key assumptions
IKT DCF Value
Base Case
$-0.97
Overvaluation 100%
DCF Value
Price $2.33
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett